Afinitor (generic name: everolimus) is used to treat various types of cancer including:
- Breast cancer
- Renal cell carcinoma
- Advanced neuroendocrine tumors
- Renal angiomyolipoma
- Subependymal giant cell astrocytoma (lesions in cells that are located on the walls of the cerebral ventricles in the brain)
- Stomach and intestinal cancers
- Lung cancer
For people with the rare genetic disorder known as tuberous sclerosis complex (TSC), it is also used to treat associated types of benign tumors in the brain, skin, kidneys, heart, eyes and lungs.
Afinitor belongs to a class of drugs called antineoplastics, which inhibit or prevent the growth and spread of tumors or malignant cells.
This makes Everolimus a member of the class known as mTOR kinase inhibitors, which inhibit the mechanistic target of rapamycin (mTOR). By inhibiting mTORs, everolimus restricts tumor growth.
Afinitor may be prescribed for use alone or with other medications.
Reviews
There are no reviews yet.